Journal of Pain and Symptom Management
Volume 23, Issue 5 , Pages 417-423 , May 2002

Impact of Dyspnea, Pain, and Fatigue on Daily Life Activities in Ambulatory Patients with Advanced Lung Cancer

  • Keiko Tanaka, MD

      Affiliations

    • Psycho-Oncology Division, National Cancer Center Research Institute East, Chiba, Japan
    • Thoracic Oncology Division, National Cancer Center Hospital East, Chiba, Japan
    • Palliative Care Unit, National Cancer Center Hospital East, Chiba, Japan
  • ,
  • Tatsuo Akechi, MD, PhD

      Affiliations

    • Psycho-Oncology Division, National Cancer Center Research Institute East, Chiba, Japan
    • Psychiatry Division, National Cancer Center Hospital East, Chiba, Japan
  • ,
  • Toru Okuyama, MD, PhD

      Affiliations

    • Psycho-Oncology Division, National Cancer Center Research Institute East, Chiba, Japan
  • ,
  • Yutaka Nishiwaki, MD

      Affiliations

    • Thoracic Oncology Division, National Cancer Center Hospital East, Chiba, Japan
  • ,
  • Yosuke Uchitomi, MD, PhD

      Affiliations

    • Psycho-Oncology Division, National Cancer Center Research Institute East, Chiba, Japan
    • Corresponding Author InformationAddress reprint requests to: Yosuke Uchitomi, MD, PhD, Psycho-Oncology Division, National Cancer Center Research Institute East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan

,Accepted 4 August 2001.

References 

  1. Pisani P, Parkin DM, Bray F, et al.  Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;24:18–29
  2. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer?. JAMA. 2000;283:2975–2978
  3. Ahmedzai SH, Walsh D. Palliative medicine and modern cancer care. Semin Oncol. 2000;27:1–6
  4. Sarna L. Lung cancer. In:  Holland JC editors. Psycho-Oncology. New York: Oxford University Press; 1998;p. 340–348
  5. Cooley M. Symptoms in adults with lung cancer (a systematic research review). J Pain Symptom Manage. 2000;19:137–153
  6. McCorkle R, Benoliel JQ. Symptom distress, current concerns and mood disturbance after diagnosis of life threatening disease. Soc Sci Med. 1983;17:431–438
  7. Degner LF, Sloan JA. Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995;10:423–431
  8. Hopwood S, Stephens RJ, on behalf of the Medical Research Council Lung Cancer Working Party . Symptoms at presentation for treatment in patients with lung cancer (implications for evaluation of palliative care). Br J Cancer. 1995;71:633–636
  9. Muers MF, Round CE, On behalf of the group . Palliation of symptoms in non-small cell lung cancer (a study by the Yorkshire Regional Cancer Organization Thoracic Group). Thorax. 1993;48:339–343
  10. Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer (an international collaborative study). J Pain Symptom Manage. 1996;12:3–10
  11. Grond S, Zech D, Diefenbach C, et al.  Prevalence and pattern of symptoms in patients with cancer pain (a prospective evaluation of 1635 cancer patients referred to a pain clinic). J Pain Symptom Manage. 1994;9:372–382
  12. Krech RL, Davis J, Walsh D, et al.  Symptoms of lung cancer. Palliat Med. 1992;48:309–315
  13. Higginson I, McCarthy M. Measuring symptoms in terminal cancer; are pain and dyspnoea controlled?. J Royal Soc Med. 1989;82:264–267
  14. Kurtz ME, Given B, Kurtz JC, et al.  The interaction of age, symptoms, and survival status on physical and mental health of patients with cancer and their families. Cancer. 1994;74(Suppl 7):2071–2078
  15. Sarna L, McCorkle R. Burden of care and lung cancer. Cancer Pract. 1996;4:245–251
  16. Tanaka K, Akechi T, Okuyama T, et al.  Development and validation of the Cancer Dyspnoea Scale (a multidimensional, brief, self-rating scale). Br J Cancer. 2000;82:800–805
  17. Okuyama T, Tanaka K, Akechi T, et al.  Fatigue in ambulatory patients with advanced lung cancer (prevalence, correlated factors and screening). J Pain Symptom Manage. 2001;22:554–564
  18. Cleeland CS. Pain assessments in cancer. In:  Osoba D editors. Effect of cancer on quality of life. Boca Raton, FL: CRC Press, Inc; 1991;p. 293–305
  19. Cleeland CS. In: Measurement of pain by subjective report. In (Charpman CR, Loeser JD. Issues in pain measurement. Vol.12 of Advances in pain research and therapy). New York: Raven Press; 1989;p. 391–403
  20. Cleeland CS, Nakamura Y, Mendoza TR, et al.  Dimensions of the impact of cancer pain in a four country sample (new information from multidimensional scaling). Pain. 1996;67:267–273
  21. Baldessarini RJ, Finklestein S, Arana GW. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiat. 1983;40:569–573
  22. Ahmedzai S. Palliation of respiratory symptoms. In:  Doyle D,  Hanks GWC,  MacDonald N editor. Oxford textbook of palliative medicine. Oxford: Oxford University Press; 1998;p. 583–616
  23. Bruera E. Schmitz B, Pither J, et al. The frequency and correlateds of dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2000;19;357–362:
  24. Masssie MJ, Holland JC. Depression and the cancer patients. J Clin Psychiatry. 1990;51(Suppl):12–17discussion 18–19
  25. Derogatis LR, Morrow GR, Fetting J, et al.  The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–757
  26. Minagawa H, Uchitomi Y, Yamawaki S, et al.  Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer. 1996;78:1131–1137

PII: S0885-3924(02)00376-7

Journal of Pain and Symptom Management
Volume 23, Issue 5 , Pages 417-423 , May 2002